Pharmacokinetic disposition and faecal excretion of pyrantel embonate following oral administration in horses

Journal of Veterinary Pharmacology and Therapeutics

Volumn 24, Issue 1, 2001, Pages 77-79

  Gokbulut, C ^a   Nolan, A M ^a   Mckellar, Q A ^b  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b MOREDUN RESEARCH INSTITUTE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PYRANTEL EMBONATE;

AREA UNDER THE CURVE; ARTICLE; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG DISPOSITION; DRUG EXCRETION; DRUG HALF LIFE; FECES; HORSE; NONHUMAN; PRIORITY JOURNAL;

ADMINISTRATION, ORAL; ANIMALS; ANTINEMATODAL AGENTS; FECES; HORSE DISEASES; HORSES; MALE; NEMATODE INFECTIONS; PYRANTEL PAMOATE;

EQUIDAE; EQUUS CABALLUS;

EID: 0035029514     PISSN: 01407783     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2885.2001.00305.x     Document Type: Article

References (6)

1. The kinetic disposition of pyrantel citrate and pamoate and their efficacy against pyrantel-resistant Oesophagostomum dentatum in pigs
2. The comparative metabolism of pyrantel in five species
3. Pharmacokinetics, pharmacodynamics and faecal persistence of morantel in cattle and goats
4. Chemotherapy of gastrointestinal nematodiasis in equines
5. Controlled efficacy study of the bioequivalence of Strongid C and generic pyrantel tartrate in horses